7月1日,宜联生物宣布,正式聘任周伟昌博士为公司首席技术官(CTO)。公司称,周伟昌在生物医药方面丰富的行业经验将帮助宜联生物加强创新管线的全球化开发进程。此前,周伟昌曾历任药明生物执行董事、首席技术官、全球生物制剂开发及运营总裁等重要职位。在2012年加入药明生物前,其曾在Genzyme Corporation(现为Sanofi的一部分)、PDL BioPharma Inc.和Merck & ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.